292 related articles for article (PubMed ID: 26689152)
1. CD155/CD226-interaction impacts on the generation of innate CD8(+) thymocytes by regulating iNKT-cell differentiation.
Georgiev H; Ravens I; Shibuya A; Förster R; Bernhardt G
Eur J Immunol; 2016 Apr; 46(4):993-1003. PubMed ID: 26689152
[TBL] [Abstract][Full Text] [Related]
2. CD226 interaction with CD155 impacts on retention and negative selection of CD8 positive thymocytes as well as T cell differentiation to follicular helper cells in Peyer's Patches.
Danisch S; Qiu Q; Seth S; Ravens I; Dorsch M; Shibuya A; Shibuya K; Förster R; Bernhardt G
Immunobiology; 2013 Feb; 218(2):152-8. PubMed ID: 22429743
[TBL] [Abstract][Full Text] [Related]
3. CD155 is involved in negative selection and is required to retain terminally maturing CD8 T cells in thymus.
Qiu Q; Ravens I; Seth S; Rathinasamy A; Maier MK; Davalos-Misslitz A; Forster R; Bernhardt G
J Immunol; 2010 Feb; 184(4):1681-9. PubMed ID: 20048123
[TBL] [Abstract][Full Text] [Related]
4. β-Catenin is required for the differentiation of iNKT2 and iNKT17 cells that augment IL-25-dependent lung inflammation.
Berga-Bolaños R; Sharma A; Steinke FC; Pyaram K; Kim YH; Sultana DA; Fang JX; Chang CH; Xue HH; Heller NM; Sen JM
BMC Immunol; 2015 Oct; 16():62. PubMed ID: 26482437
[TBL] [Abstract][Full Text] [Related]
5. Transcription factor Bcl11b sustains iNKT1 and iNKT2 cell programs, restricts iNKT17 cell program, and governs iNKT cell survival.
Uddin MN; Sultana DA; Lorentsen KJ; Cho JJ; Kirst ME; Brantly ML; Califano D; Sant'Angelo DB; Avram D
Proc Natl Acad Sci U S A; 2016 Jul; 113(27):7608-13. PubMed ID: 27330109
[TBL] [Abstract][Full Text] [Related]
6. Altered Innate-like T Cell Development in Vα14-Jα18 TCRα Transgenic Mice.
Lau I; de Amat Herbozo C; Kuypers M; Lin Q; Paget C; Mallevaey T
Immunohorizons; 2020 Dec; 4(12):797-808. PubMed ID: 33323387
[TBL] [Abstract][Full Text] [Related]
7. Intranodal interaction with dendritic cells dynamically regulates surface expression of the co-stimulatory receptor CD226 protein on murine T cells.
Seth S; Qiu Q; Danisch S; Maier MK; Braun A; Ravens I; Czeloth N; Hyde R; Dittrich-Breiholz O; Förster R; Bernhardt G
J Biol Chem; 2011 Nov; 286(45):39153-63. PubMed ID: 21937446
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+ T and invariant NKT cells.
Sintes J; Cuenca M; Romero X; Bastos R; Terhorst C; Angulo A; Engel P
J Immunol; 2013 Jan; 190(1):21-6. PubMed ID: 23225888
[TBL] [Abstract][Full Text] [Related]
9. Increased Soluble CD226 in Sera of Patients with Cutaneous T-Cell Lymphoma Mediates Cytotoxic Activity against Tumor Cells via CD155.
Takahashi N; Sugaya M; Suga H; Oka T; Kawaguchi M; Miyagaki T; Fujita H; Inozume T; Sato S
J Invest Dermatol; 2017 Aug; 137(8):1766-1773. PubMed ID: 28395975
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function.
Zhang L; Tschumi BO; Corgnac S; Rüegg MA; Hall MN; Mach JP; Romero P; Donda A
J Immunol; 2014 Aug; 193(4):1759-65. PubMed ID: 25015820
[TBL] [Abstract][Full Text] [Related]
11. Abundance of follicular helper T cells in Peyer's patches is modulated by CD155.
Seth S; Ravens I; Kremmer E; Maier MK; Hadis U; Hardtke S; Förster R; Bernhardt G
Eur J Immunol; 2009 Nov; 39(11):3160-70. PubMed ID: 19688744
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112).
Tahara-Hanaoka S; Shibuya K; Onoda Y; Zhang H; Yamazaki S; Miyamoto A; Honda S; Lanier LL; Shibuya A
Int Immunol; 2004 Apr; 16(4):533-8. PubMed ID: 15039383
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD226 antagonizes apoptotic cell death in murine thymocytes.
Fang L; Zhang X; Miao J; Zhao F; Yang K; Zhuang R; Bujard H; Wei Y; Yang A; Chen L; Jin B
J Immunol; 2009 May; 182(9):5453-60. PubMed ID: 19380793
[TBL] [Abstract][Full Text] [Related]
14. SLAM-associated protein favors the development of iNKT2 over iNKT17 cells.
Michel ML; Lenoir C; Massot B; Diem S; Pasquier B; Sawa S; Rignault-Bricard R; Lehuen A; Eberl G; Veillette A; Leite-de-Moraes M; Latour S
Eur J Immunol; 2016 Sep; 46(9):2162-74. PubMed ID: 27338553
[TBL] [Abstract][Full Text] [Related]
15. TIGIT-Fc alleviates acute graft-versus-host disease by suppressing CTL activation via promoting the generation of immunoregulatory dendritic cells.
Zhang D; Hu W; Xie J; Zhang Y; Zhou B; Liu X; Zhang Y; Su Y; Jin B; Guo S; Zhuang R
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):3085-3098. PubMed ID: 29960041
[TBL] [Abstract][Full Text] [Related]
16. Eomes transcription factor is required for the development and differentiation of invariant NKT cells.
Shimizu K; Sato Y; Kawamura M; Nakazato H; Watanabe T; Ohara O; Fujii SI
Commun Biol; 2019; 2():150. PubMed ID: 31044175
[TBL] [Abstract][Full Text] [Related]
17. Differential dependence on nuclear factor-κB-inducing kinase among natural killer T-cell subsets in their development.
Noma H; Eshima K; Satoh M; Iwabuchi K
Immunology; 2015 Sep; 146(1):89-99. PubMed ID: 25988531
[TBL] [Abstract][Full Text] [Related]
18. KLF13 sustains thymic memory-like CD8(+) T cells in BALB/c mice by regulating IL-4-generating invariant natural killer T cells.
Lai D; Zhu J; Wang T; Hu-Li J; Terabe M; Berzofsky JA; Clayberger C; Krensky AM
J Exp Med; 2011 May; 208(5):1093-103. PubMed ID: 21482696
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: the chemokine receptor CXCR3 retains invariant NK T cells in the thymus.
Drennan MB; Franki AS; Dewint P; Van Beneden K; Seeuws S; van de Pavert SA; Reilly EC; Verbruggen G; Lane TE; Mebius RE; Deforce D; Elewaut D
J Immunol; 2009 Aug; 183(4):2213-6. PubMed ID: 19620294
[TBL] [Abstract][Full Text] [Related]
20. IL15 Stimulation with TIGIT Blockade Reverses CD155-mediated NK-Cell Dysfunction in Melanoma.
Chauvin JM; Ka M; Pagliano O; Menna C; Ding Q; DeBlasio R; Sanders C; Hou J; Li XY; Ferrone S; Davar D; Kirkwood JM; Johnston RJ; Korman AJ; Smyth MJ; Zarour HM
Clin Cancer Res; 2020 Oct; 26(20):5520-5533. PubMed ID: 32591463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
